Alkem Laboratories (NSE:ALKEM) Accounts Payable & Accrued Expense : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories Accounts Payable & Accrued Expense?

Alkem Laboratories's quarterly accounts payable & accrued expense increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹12,327 Mil) but then declined from Sep. 2023 (₹12,327 Mil) to Dec. 2023 (₹0 Mil).

Alkem Laboratories's annual accounts payable & accrued expense increased from Mar. 2021 (₹13,590 Mil) to Mar. 2022 (₹15,096 Mil) and increased from Mar. 2022 (₹15,096 Mil) to Mar. 2023 (₹15,384 Mil).

Alkem Laboratories Accounts Payable & Accrued Expense Historical Data

The historical data trend for Alkem Laboratories's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories Accounts Payable & Accrued Expense Chart

Alkem Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

11,745.40

12,031.30

13,590.40

15,096.00

15,383.50

Alkem Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															-	15,383.50	-	12,326.60	-

Alkem Laboratories Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Alkem Laboratories (NSE:ALKEM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

539523:India

Address

Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.alkemlabs.com

Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines